← Back to browse
HR 6624 Cleared committee

Requires a federal license to export digital sequences of synthetic DNA or RNA to foreign entities of concern, such as foreign governments and persons they own or control.

Official title: Biological Intellectual Property Protection Act of 2025

Next stop House floor: awaiting a vote
Timeline each lane is a chamber; dates pull from congress.gov actions
House
Introduced 11-DEC-2025
Referred 11-DEC-2025
Approved by committee 22-APR-2026
Key points
  • Adds a new section 1758A to the Export Control Reform Act of 2018 requiring a license to export, reexport, or transfer within a foreign country digital sequences of synthetic DNA or RNA to foreign entities of concern.
  • Sets the license requirement to take effect no later than one year after the section's enactment.
  • Exempts information described in section 734.3(b) of the Export Administration Regulations, which covers certain published and otherwise publicly available information.
  • Defines a foreign entity of concern as a government entity of a foreign country of concern, a person subject to that country's jurisdiction, or a foreign person owned, directed, or controlled by either.
  • Includes sense-of-Congress findings that the People's Republic of China seeks access to sensitive U.S. data and intellectual property, and states that the United States should control exports of synthetic DNA and RNA sequences to foreign adversaries.
AI-generated from the Introduced in House text of 11-DEC-2025 · verify · report an error
Official CRS summary

No CRS summary yet. CRS writes one for most bills, often months after they move.

CRS is the Library of Congress's nonpartisan research office. Check on congress.gov
Committee referrals (1) Policy area

International Affairs

Sponsor Warren Davidson (R-OH) Cosponsors · 11
■ 8 R■ 3 D